» Articles » PMID: 26045247

Receptor-based Virtual Screening Protocol for Drug Discovery

Overview
Publisher Elsevier
Specialties Biochemistry
Biophysics
Date 2015 Jun 6
PMID 26045247
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Computational aided drug design (CADD) is presently a key component in the process of drug discovery and development as it offers great promise to drastically reduce cost and time requirements. In the pharmaceutical arena, virtual screening is normally regarded as the top CADD tool to screen large libraries of chemical structures and reduce them to a key set of likely drug candidates regarding a specific protein target. This chapter provides a comprehensive overview of the receptor-based virtual screening process and of its importance in the present drug discovery and development paradigm. Following a focused contextualization on the subject, the main stages of a virtual screening campaign, including its strengths and limitations, are the subject of particular attention in this review. In all of these stages special consideration will be given to practical issues that are normally the Achilles heel of the virtual screening process.

Citing Articles

The role of artificial intelligence in drug screening, drug design, and clinical trials.

Wu Y, Ma L, Li X, Yang J, Rao X, Hu Y Front Pharmacol. 2024; 15:1459954.

PMID: 39679365 PMC: 11637864. DOI: 10.3389/fphar.2024.1459954.


Modeling High Energy Molecules and Screening to Find Novel High Energy Candidates.

Rachamim M, Domb A, Goldblum A ACS Omega. 2024; 9(42):42709-42720.

PMID: 39464471 PMC: 11500160. DOI: 10.1021/acsomega.4c01070.


Structure features of FabG and virtual screening of allosteric inhibitors.

Xu K, Zhong J, Li J, Cao Y, Wei L Front Mol Biosci. 2024; 11:1472252.

PMID: 39398278 PMC: 11467476. DOI: 10.3389/fmolb.2024.1472252.


Structure-based virtual screening of mangiferin derivatives with antidiabetic action: a molecular docking and dynamics study and MPO-based drug-likeness approach.

da Silva Lopes F, Lucio F, da Rocha M, Oliveira V, Alexandre Roberto C, Marinho M 3 Biotech. 2024; 14(5):135.

PMID: 38665880 PMC: 11039600. DOI: 10.1007/s13205-024-03978-9.


A Comparative Analysis on the Potential Anticancer Properties of Tetrahydrocannabinol, Cannabidiol, and Tetrahydrocannabivarin Compounds Through In Silico Approach.

Gallardo A, Gutierrez M, Gomez L, Delos Reyes P, Dones S, Dumbrique M Asian Pac J Cancer Prev. 2024; 25(3):839-856.

PMID: 38546067 PMC: 11152392. DOI: 10.31557/APJCP.2024.25.3.839.